AliveCor lands FDA approval to sell its smartphone electrocardiogram recorder to patients without a prescription, with shipments slated to begin in March.
San Francisco-based AliveCor won FDA clearance to sell its smartphone heart monitor without a prescription for the 1st time, moving the device into a growing realm of self-tracking apps for the consumer market.
AliveCor is now taking pre-orders for the device, which was previously available only via prescription, and the shipments are expected to begin in March, according to a company statement.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1lX198R
Cap comentari:
Publica un comentari a l'entrada